AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metarv 1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Arvantis Pharmaceuticals

Salt Composition

Metformin (1000mg)

Overview Metarv 1000mg Tablet SR

Diabetace 1000mg Extended-Release tablets manage type 2 diabetes mellitus by regulating blood glucose, thereby mitigating severe diabetic complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, consume Diabetace 1000mg ER with food, consistently at the same time daily. Discontinue only under physician guidance. Maintaining a healthy lifestyle, including adhering to prescribed diet and exercise plans, is crucial for effective diabetes management. Common adverse effects include nausea, diarrhea, vomiting, gas, weakness, indigestion, stomach pain, headaches, and appetite loss. Concurrent use with other antidiabetic drugs, alcohol, or missed doses may lead to hypoglycemia (low blood sugar). Regular blood glucose monitoring is essential. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should seek medical counsel before use. Baseline kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to reduce the potential for adverse reactions.

Primary Ingredients of Metarv 1000mg Tablet SR

No text provided. Please provide the text you would like me to rephrase.

Uses of Metarv 1000mg Tablet SR

Management of type 2 diabetes and polycystic ovary syndrome

Major Benefits of Metarv 1000mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Metarv 1000mg sustained-release tablet should be administered with a meal.

Common Side effects of Metarv 1000mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metarv 1000mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Metarv 1000mg Tablet SR whole; do not crush, chew, or break it. Administer this medicine with food.

How Metarv 1000mg Tablet SR works:

Metarv 1000mg Extended-Release tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Metarv 1000mg SR tablets is contraindicated.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metarv 1000mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; however, clinical data from human trials remain scarce.

Breast feedingBreast feedingCAUTION

Extended-release Metarv 1000mg tablets require careful consideration while breastfeeding. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metarv 1000mg Tablet SR cautiously, potentially requiring a modified dosage. Physician consultation is advised. Metarv 1000mg Tablet SR is contraindicated for individuals with severe kidney disease.

LiverLiverUNSAFE

Extended-release Metarv 1000mg tablets are contraindicated for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Metarv 1000mg Tablet SR :

Should you forget a dose of your Metarv 1000mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metarv 1000mg Tablet SR

LabelValue
Type of Compound Guanidine-based compound
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Metarv 1000mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's own insulin. Consequently, blood glucose levels rise. Metarv 1000mg Tablet SR employs a multifaceted approach to lower elevated blood sugar. This medication reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metarv 1000mg Tablet SR has demonstrated weight reduction in overweight and obese patients. This medication may also lead to slight weight decrease in overweight or obese individuals predisposed to diabetes. Furthermore, weight loss can occur in patients with insulin sensitivity or resistance. However, self-initiation of Metarv 1000mg Tablet SR for weight management is inadvisable; physician consultation is required.
Metarv 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose levels by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metarv 1000mg Tablet SR monotherapy infrequently results in hypoglycemia due to its mechanism of action which avoids excessive pancreatic insulin release. Beyond glycemic control, it also aids in weight management.
Metarv 1000mg sustained-release tablets generally don't induce drowsiness and are well-received. Infrequently, though, Metarv 1000mg SR tablets can lead to sleep disturbances and insomnia. Drowsiness can signal a severe adverse reaction known as lactic acidosis, especially prevalent in individuals with impaired kidney function. Seek medical attention if fatigue or sleepiness develops during Metarv 1000mg SR treatment.
Administer Metarv 1000mg Tablet SR either with or following a meal. The tablets should be swallowed whole with water; do not crush or chew them. For once-daily prescriptions, morning ingestion with breakfast is recommended. Twice-daily regimens should involve one tablet in the morning and one in the evening, taken with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metarv 1000mg Tablet SR with food helps mitigate potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals diagnosed with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This results in elevated blood glucose concentrations. Metarv 1000mg Tablet SR employs a multi-faceted approach to lower these elevated blood sugar levels. The medication reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream. It also promotes a more effective response to naturally produced insulin.
Metarv 1000mg SR tablets have demonstrated weight reduction effects in overweight and obese patients. This weight loss may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-medicating with this drug for weight management is strongly discouraged; physician consultation is essential.
Metarv 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose levels by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metarv 1000mg Tablet SR monotherapy infrequently leads to hypoglycemia due to its inhibition of excessive insulin release. Beyond glycemic control, this medication also aids in weight management.
Metarv 1000mg sustained-release tablets generally do not induce drowsiness and are typically well-received. Infrequently, however, Metarv 1000mg sustained-release tablets can lead to sleep disturbances and insomnia. Somnolence may signal a severe adverse reaction known as lactic acidosis, especially in individuals with impaired renal function. Seek medical advice if fatigue or sleepiness develops during Metarv 1000mg sustained-release tablet use.
Administer Metarv 1000mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily prescriptions, morning administration with breakfast is recommended. Twice-daily regimens should involve morning and evening doses, taken with breakfast and dinner respectively. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metarv 1000mg SR tablets with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their endogenous insulin. This leads to elevated blood glucose levels. Metarv 1000mg Tablet SR employs a multifaceted approach to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream. Consequently, the body's utilization of naturally produced insulin is also improved.
Metarv 1000mg sustained-release tablets have demonstrated weight reduction in overweight and obese patients. This effect may also be observed, albeit modestly, in overweight and obese individuals predisposed to diabetes. Furthermore, weight loss can occur in patients with insulin sensitivity or resistance. However, self-medicating with this drug for weight management is inadvisable; physician consultation is necessary.
Metarv 1000mg Tablet SR is an initial treatment option for hyperglycemia. This medication manages blood glucose by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, Metarv 1000mg Tablet SR monotherapy infrequently leads to hypoglycemia due to its inhibition of excessive insulin release. Beyond glycemic control, it also aids in weight management.
Metarv 1000mg extended-release tablets generally don't induce drowsiness and are typically well-tolerated. Infrequently, though, Metarv 1000mg extended-release tablets can lead to sleep disturbances or insomnia. Somnolence might signal a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metarv 1000mg extended-release tablet treatment.
Administer Metarv 1000mg Tablet SR orally, with or following a meal. The tablets should be swallowed whole with water; avoid crushing or chewing. For once-daily regimens, ingestion with breakfast is recommended. Twice-daily prescriptions should be divided, one dose in the morning and one in the evening. Three times daily, distribute the doses with breakfast, lunch, and dinner. Consuming Metarv 1000mg Tablet SR with food may mitigate gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metarv 1000mg Tablet SR
36
MRP 42
13% off